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Monoclonal gammopathy occurs in one-third of the patients with mucosa-associated lymphoid tissue lymphoma (MALT lympho-
ma). However, monoclonal gammopathy has been rarely reported in Korea. Paraprotenemia accompanying MALT lymphoma is 
strongly correlated with involvement of the bone marrow, and this involvement leads to the progression of the disease. Here, we 
present a case of a 66-yr-old man diagnosed with IgM monoclonal gammopathy and stage IV extranodal marginal zone lympho-
ma of the small intestine, with the involvement of the bone marrow. 
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INTRODUCTION
Extranodal marginal zone B-cell lymphoma (ENMZL) of 
the mucosa-associated lymphoid tissue (MALT) accounts 
for 7–8% of all newly diagnosed B-cell lymphomas [1]. Usu-
ally ENMZL is an indolent disease, but some patients have 
shown dissemination of ENMZL into the bone marrow [2, 3].
Some studies on monoclonal gammopathy have suggested 
the potential of ENMZL cells to produce immunoglobulins 
[4-6]. The prevalence of monoclonal gammopathy in MALT 
lymphoma patients was reported to be 36% by Wöhrer et al. 
[7]. They suggested that the change in the paraprotein con-
centration may reflect an antitumor response. One study 
described that the presence of a monoclonal spike is strongly 
correlated with bone marrow involvement, which is indica-
tive of advanced stages of the disease [8].
In Korea, monoclonal gammopathy in MALT lymphoma 
has been rarely reported until recently [9]. Here, we report 
a case of a 66-yr-old man diagnosed with IgM monoclonal 
gammopathy and ENMZL of the small intestine.
CASE REPORT
A 66-yr-old man was admitted to the hospital because of 
back pain and dyspnea on exertion. The patient had no his-
tory of medical illness, and he had good health until this 
hospital visit. Complete blood count analysis revealed that 
the hemoglobin level was 8.6 g/dL with microcytic and hy-
pochromic anemia. The iron panel indicated that his ane-
mia was caused by iron deficiency: the serum ferritin level 
was 5.62 ng/mL (normal range, 30–310 ng/mL) and trans-
ferrin saturation was 7.34% (20-55%). His serum chemical 
values were as follows: total protein, 7.9 g/dL (normal range, 
6.4–8.3 g/dL); albumin, 2.7 g/dL (3.4–5.1 g/dL); lactate de-
hydrogenase level, 366 IU/L (240–480 IU/L); calcium level, 
8.0 mg/dL (8.4–10.0 mg/dL); blood urea nitrogen, 12.7 mg/
dL (6.0–20.0 mg/dL); and creatinine level, 0.8 mg/dL (0.5–
1.2 mg/dL). Serum protein electrophoresis showed an ab-
normal zone of restriction in the gamma globin lane. The 
level of the M-peak was 2.1 g/dL. Serum immunofixation 
electrophoresis demonstrated monoclonal gammopathy of Kim DY, et al.  •  A Case of IgM Paraprotenemia in MALToma
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the IgM lambda type (Fig. 1).
Computed tomography (CT) was performed because the 
patient developed abrupt severe abdominal pain. The CT 
scan showed a circumferential huge mass in the ileal loop 
along with perforation and multiple lymphadenopathy. The 
patient underwent an emergency operation, and he was di-
agnosed with ENMZL of MALT with focal large cell trans-
formation (diffuse large B-cell lymphoma) of the small bowel. 
Histologic examination revealed the MZ tumor cells infil-
trating around the reactive follicles and disseminating to the 
small bowel mucosa (Fig. 2A). The tumor cells were small to 
medium-sized, and they contained slightly irregular nuclei 
with moderately dispersed chromatin and inconspicuous 
nucleoli. The intestinal crypt epithelium was often invaded 
and destroyed by these tumor cells, leading to the formation 
of the lymphoepithelial lesion (Fig. 2B). Plasmacytic differ-
entiation was observed, which was verified by immunohis-
tochemistry for CD38 (Fig. 2C, D). Immunohistochemical 
analysis showed that the neoplastic lymphocytes were posi-
tive for CD20 and negative for CD5, CD10, CD23, and cy-
clin D1.
Bone marrow biopsy was performed, which showed bone 
marrow involvement of ENMZL. The bone marrow aspi-
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Fig. 1.	Serum	immunofixation	electrophoresis	showed	a	dense	abnormal	
zone	of	restriction	in	the	IgM	lane	and	in	the	lambda	light	chain	lane.
Fig. 2.	Microscopic	features	of	the	small	intestinal	mucosa-associated	lymphoid	tissue	lymphoma.	(A)	The	tumor	cells	of	the	marginal	zone	surround	the	reactive	
follicles	and	diffusely	infiltrate	the	mucosa	(hematoxylin	and	eosin	stain,	×100).	(B)	A	lymphoepithelial	lesion	showing	destruction	of	the	intestinal	crypts	by	tu-
mor	cells	(arrows)	(hematoxylin	and	eosin	stain,	×400).	(C)	Plasma	cells	with	eccentric	nuclei	are	admixed	with	small	lymphocytes	(hematoxylin	and	eosin	stain,	
×400).	(D)	Plasma	cells	are	highlighted	(brown)	by	immunohistochemical	staining	for	CD38	(Immunohistochemistry,	×400).
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rate showed 20% cellularity and 2.1% of plasma cells (Fig. 
3B). Bone marrow biopsy revealed focal infiltration of the 
neoplastic lymphoid cells, which showed a morphologic 
spectrum, including small lymphocytes with inconspicuous 
nucleoli and plasmacytoid lymphocytes (Fig. 3C).
A whole-body positron emission tomography (PET)-CT 
scan revealed a hypermetabolic mass (diameter, 7 cm) in the 
ileum and multiple abdominopelvic lymph node metasta-
ses. The patient was diagnosed with IgM monoclonal gam-
mopathy and stage IV ENMZL of the small intestine involv-
ing the bone marrow and multiple abdominopelvic lymph 
nodes. The patient was administered a combination chemo-
therapy of cyclophosphamide (750 mg/m
2 on day 1), adria-
mycin (50 mg/m
2 on day 1), vincristine (1.4 mg/m
2 on day 
1), prednisolone (100 mg/day on days 1–5), and rituximab 
(375 mg/m
2 on day 1) every 21 days. After the fourth cycle 
of chemotherapy, the patient recovered, and he is now being 
followed-up on an outpatient basis.
DISCUSSION
ENMZL of the MALT accounts for 7–8% of non-Hodg-
kin’s lymphomas (NHL) [1]. ENMZL may occur in the stom-
ach, intestine, orbit, lung, thyroid, salivary gland, skin, soft 
tissues, bladder, kidney, and central nervous system. The 
stomach is the most common site of involvement [10]. EN-
MZL is diagnosed on the basis of morphological examina-
tion and immunohistochemistry, including a panel of mono-
clonal antibodies against CD20, CD79a, CD3, CD10, CD23, 
CD43, Bcl-2, and cyclin D1, according to the Revised Euro-
pean American Lymphoma (REAL)/WHO classification 
[11]. ENMZL is regarded as an indolent disease, but it some-
times progresses to a more aggressive histopathogenesis and 
shows resistance to therapy. For patients who present with 
an unfavorable International Prognostic Index score and 
disseminated disease involving extranodal sites, the prog-
nosis is relatively poor [2, 3].
The association of monoclonal gammopathy with B cell 
NHL is a well-known phenomenon, although the frequency 
varies between the histological subtypes. Approximately 50% 
of patients with lymphoplasmacytic lymphoma have ele-
vated serum Ig levels. Paraproteinemias are often noted in 
patients with CLL and are less common in patients with dif-
fuse large B-cell lymphoma [12]. The presence of monoclo-
nal gammopathy has been reported in up to 50% of patients 
with splenic MZL, and it has been reported in 36% of those 
Fig. 3.	Findings	of	peripheral	blood	smear	and	bone	marrow	study.	(A)	The	
peripheral	blood	smear	shows	a	plasmacytoid	lymphocyte	(Wright	stain,	
×1,000).	(B)	The	bone	marrow	aspirate	contains	2.1%	plasma	cells	(Wright	
stain,	×1,000).	(C)	Bone	marrow	biopsy	showing	interstitial	infiltration	of	
mature	lymphocytes	(hematoxylin	and	eosin	stain,	×400).
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with ENMZL [7, 13].
Asatiani et al. [8] showed that monoclonal gammopathy 
in patients with ENMZL was associated with bone marrow 
involvement and a tendency toward large cell transforma-
tion. This study showed that the common Ig in monoclonal 
gammopathy was IgG, while the incidence of IgM was low 
(3.8%; 1/26). Our case showed bone marrow involvement 
and transformation from marginal zone B-cell lymphoma 
to large cell lymphoma in ENMZL.
The association of ENMZL with monoclonal gammopa-
thy has been rarely reported in Korea. One case of gastric 
MALT lymphoma with monoclonal gammopathy but ab-
sence of Helicobacter pylori infection was reported recently 
in Korea [9]. Monoclonal gammopathy is negatively associ-
ated with response to eradication of H. pylori in gastric 
MALT lymphoma. The effect of monoclonal gammopathy 
on the treatment response in cases of small intestine MALT 
lymphoma remains unknown. The effect of changing para-
protein levels on the treatment response was observed: our 
patient who had a paraprotein level of 2.1–0.8 g/dL after the 
fourth cycle of chemotherapy showed an antitumor response. 
Reitter et al. [14] insisted that the paraprotein level should 
be routinely checked at the staging of MALT lymphoma 
and suggested that the change in the paraprotein level may 
be valuable for monitoring the treatment response.
Our report shows a rare case of monoclonal gammopathy 
in a patient with MALT lymphoma. Further investigations 
are required to determine whether the routine check for 
paraprotein level is needed and whether the presence of 
monoclonal gammopathy can assist in the prognostic strati-
fication of patients with ENMZL.
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